
AIRA Matrix
AI-powered image analysis and predictive analytics for drug discovery, preclinical research, and clinical diagnostics.
Overview
AIRA Matrix is an artificial intelligence company that develops image analysis and predictive analytics solutions for healthcare and life sciences applications. Based in Thane, Maharashtra, India, the company combines expertise in these two areas to build AI tools aimed at improving pharmaceutical research and healthcare outcomes.
AIRA Matrix's solutions are designed to reduce turnaround times, minimize errors, and ensure consistency across workflows. They support the combination of multimodal data for comprehensive insights, enable analysis beyond the capabilities of traditional methods, and address risk stratification and predictive processes.
Drug Discovery
- Offers AI tools focused on optimizing time and resources spent during the drug discovery phase
- Includes a Predictive Toxicology module to support early-stage safety evaluation
Preclinical / Research
- Provides solutions to accelerate preclinical pathology workflows
- Modules include Quality Control, Safety Assessment, and Image Management
Clinical
- Supports informed therapy decisions at the clinical stage
- Offerings include Quality Control, Prostate Diagnostics, Prostate Stratification, and Prostate Prediction
Services
- Provides customized services to address specific image analysis and study management challenges
- Uses established frameworks to enable rapid deployment while maintaining efficiency and quality
Knowledge and Research
- Publishes resources covering the role of AI in digital pathology, including patents, posters, publications, and conference contributions
AIRA Matrix serves organizations across the pharmaceutical and healthcare sectors, with a focus on digital pathology and AI-driven analysis at each stage from drug discovery through clinical application.